|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 13, 2017 ) Latin America Multiple Myeloma Therapeutics Market is projected to reach USD 1.21 Billion by 2021, at a CAGR of 5.33% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/latin-america-multiple-myeloma-therapeutics-market-862/
Multiple myeloma is a specifically fatal but less common type of blood cancer effects in eventual patient deteriorations even after therapy and is universally considered as lethal. Incidence of multiple myeloma is increasing with each passing year. The disease mostly affects the aged, assumed the average age of disease start at around 70 years.
Free sample for the report is available at
http://www.marketdataforecast.com/market-reports/latin-america-multiple-myeloma-therapeutics-market-862/request-sample
Expanding indications of existing drugs, emergence of new and promising drugs, increasing incidence of multiple myeloma and increasing use of drugs already on the market are fuelling growth of the market. Moreover, growth is being driven by the drive to novel drugs in search of higher effectiveness and safety and increasing use of these high prices medicines for the treatment of the condition.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/latin-america-multiple-myeloma-therapeutics-market-862/inquire
Segmentation:
By Treatment Type:
Chemotherapy
Anthracycline antibiotic
Melphalan (Alkeran)
Liposomal doxorubicin (Doxil)
Alkylating agent
Doxorubicin (Adriamycin)
Cyclophosphamide (Neosar)
Vincristine (Oncovin)
Carmustine (BiCNU)
Targeted therapy
Proteasome inhibitor
Bortezomib (Velcade)
Carfilzomib (Kyprolis)
By Drug Type
Corticosteroids
Dexamethasone (Decadron)
Prednisone (Deltasone/Orasone)
Immunomodulatory agents
Thalidomide (Thalomid)
Lenalidomide (Revlimid)
Arsenic trioxide (Trisenox)
Plerixafor (Mozobil)
By Region
Brazil
Mexico
Argentina
Rest of Latin America
Some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC., ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
Buy now http://www.marketdataforecast.com/cart/buy-now/latin-america-multiple-myeloma-therapeutics-market-862
The Latin America Multiple Myeloma Therapeutics Market Study covers:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
Latin America Radiotherapy Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/latin-america-radiotherapy-market-819/
Latin America Autoimmune Monoclonal Antibodies Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/latin-america-autoimmune-monoclonal-antibodies-1174/
Latin America Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/latin-america-monoclonal-antibodies-market-1188/
Latin America Neurotherapeutics Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/latin-america-neurotherapeutics-market-1274/
Latin America Immunotherapy Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/latin-america-cancer-immunotherapy-market-1416/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
